A Preliminary Cost Analysis of Schizophrenic Patients Stabilized on 1-Monthly Long Acting Paliperidone Palmitate (PP1M) Injection Switching to Paliperidone Palmitate 3-Monthly Formulation (PP3M) in the Public Sector of Hong Kong

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.1877
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Real-World Analysis of Switching Patients With Schizophrenia From Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

Drugs - Real World Outcomes
Pharmacology
2019English

Treatment Cost Comparison: Paliperidone Palmitate Versus Risperidone Long Acting in Brazil

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Budget Impact Analysis of Paliperidone Palmitate 3-Monthly for the Treatment of Schizophrenia in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

MA3 Paliperidone Palmitate Long-Acting Injection for Brazilian Non-Adherent Schizophrenic Patients: 5-Year Budget Impact Analysis From the Public Payer Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Medical Cost-Offset of Once-Monthly Paliperidone Palmitate Monotherapy and Adjunctive Therapy in 15-Month Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia

Psychiatric Services
MedicinePsychiatryMental Health
2016English

Switching From Oral Atypical Antipsychotic Monotherapy to Paliperidone Palmitate Once-Monthly in Non-Acute Patients With Schizophrenia: A Prospective, Open-Label, Interventional Study

Psychopharmacology
Pharmacology
2016English

Letter to the Editor: Is Paliperidone Palmitate More Effective Than Other Long-Acting Injectable Antipsychotics?

Psychological Medicine
PsychiatryMental HealthApplied Psychology
2018English

Corrigendum: Pharmacoeconomic Comparison of Aripiprazole Once-Monthly and Paliperidone Palmitate From a Head-To-Head Clinical Trial in Schizophrenia: A US Analysis

Drugs in Context
Molecular MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy